<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The growth transformation of human B cells by Epstein-Barr virus (EBV) is controlled by the coordinate expression of 10 latent <z:mp ids='MP_0001799'>viral</z:mp> genes </plain></SENT>
<SENT sid="1" pm="."><plain>This transforming capacity is believed to be fundamental to the involvement of the virus in human <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> of B cell origin </plain></SENT>
<SENT sid="2" pm="."><plain>EBV-negative Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (dG75) clones stably expressing one of these EBV-coded antigens, EBNA-4, have been established using an episomal-based plasmid </plain></SENT>
<SENT sid="3" pm="."><plain>EBNA-4 expression was found to upregulate the cytoskeletal protein vimentin as well as surface expression of the activation antigen CD40 </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, the presence of EBNA-4 resulted in downregulation of the Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>-associated antigen (BLA/CD77) </plain></SENT>
<SENT sid="5" pm="."><plain>These studies show for the first time that EBNA-4 modulates the expression of several cellular genes implicated in cell-growth transformation </plain></SENT>
</text></document>